Introduction
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver conditions in the United Kingdom, yet it often develops without producing any noticeable symptoms. For many people, the early signs of NAFLD are subtle or entirely absent, making it genuinely difficult to recognise without appropriate clinical assessment. Because the condition is closely linked to metabolic health factors — including weight, blood pressure, blood glucose and cholesterol — it can accompany other health concerns that a person may already be managing. Understanding the early features, recognising relevant risk factors and appreciating the role and limitations of liver-related blood tests can help inform a timely and constructive conversation with a healthcare professional. Testing, however, is not the same as diagnosis.
What Are the Early Signs of NAFLD?
Direct answer: The early signs of NAFLD are, in many cases, absent entirely. The condition often produces no noticeable symptoms, particularly in its earlier stages. Some people may experience non-specific symptoms such as unexplained fatigue, a general sense of feeling unwell, or mild discomfort in the upper-right abdomen. Because these features are not unique to NAFLD, symptoms alone cannot confirm the condition. In some instances, liver-related blood-test abnormalities may be identified incidentally before any symptoms develop, which may prompt further assessment.
Possible early features of NAFLD include:
- No noticeable symptoms
- Unexplained or persistent fatigue
- Feeling generally unwell
- Discomfort under the right ribs
- Abnormal liver-related blood-test results found incidentally
These features are not specific to NAFLD, and symptoms or blood-test results alone cannot confirm the condition.
Early NAFLD is frequently identified not because a person feels unwell, but because blood tests performed for an unrelated reason return results outside the expected reference range. This underscores the value of understanding metabolic risk factors alongside any symptomatic concerns.
What Is Non-Alcoholic Fatty Liver Disease?
Non-alcoholic fatty liver disease (NAFLD) is an umbrella term describing a spectrum of liver conditions caused by fat accumulation in the liver cells of people who drink little or no alcohol. In recent years, the condition has been reclassified within the medical community, and it is now increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD is the updated terminology that better reflects the condition's association with metabolic health factors. For the purposes of this article, the term NAFLD is retained alongside MASLD, as it remains widely searched and broadly recognised among the general public.
At its simplest, NAFLD encompasses a build-up of fat in the liver — a stage known as hepatic steatosis — that is not caused by excessive alcohol consumption. NHS guidance describes four broad stages:
- Steatosis (fatty liver): Fat accumulates in liver cells; many people at this stage experience no symptoms.
- Non-alcoholic steatohepatitis (NASH) / metabolic dysfunction-associated steatohepatitis (MASH): The liver becomes inflamed alongside fat accumulation, which can lead to liver-cell damage.
- Fibrosis: Persistent inflammation causes the formation of scar tissue around liver cells and blood vessels.
- Cirrhosis: Extensive scarring affects the liver's ability to function; this is the most advanced stage.
It is important to note that not everyone with fatty liver disease will progress through all four stages. Many people remain at the steatosis stage without developing significant liver damage, though the presence of associated metabolic conditions may influence progression over time.
Why Can NAFLD Develop Without Obvious Symptoms?
The liver is a remarkably resilient organ with a substantial reserve capacity. Even when a degree of fat accumulation or mild inflammation is present, the liver may continue to function adequately for an extended period, producing no symptoms that alert a person to the underlying change. This physiological resilience, whilst beneficial in many respects, means that liver disease — including NAFLD — can remain clinically quiet until it reaches a more advanced stage.
This is why metabolic risk factors may, in certain cases, be more informative than symptoms alone. A person with established type 2 diabetes, central weight gain, high blood pressure and elevated cholesterol may have a meaningful risk profile for NAFLD even if they feel broadly well. When blood tests are performed in this context — perhaps for an entirely separate reason — an unexpected result outside the reference range may be the first indication that liver health warrants closer attention.
It is equally important not to overstate this point: an abnormal liver test result does not automatically indicate NAFLD, and the absence of symptoms does not mean all is well. Both findings require appropriate clinical interpretation.
Who May Have a Higher Risk of NAFLD?
NHS guidance and broader clinical evidence identify a number of factors associated with a higher likelihood of developing NAFLD. These include:
- Overweight or obesity, particularly with central or abdominal fat accumulation
- Type 2 diabetes or insulin resistance
- High blood pressure (hypertension)
- Elevated cholesterol or triglycerides
- Low levels of regular physical activity
- Metabolic syndrome — the presence of several interrelated metabolic abnormalities together
- Polycystic ovary syndrome (PCOS)
- Hypothyroidism in some cases
- Certain medications, in a minority of instances
Risk increases with the number of these factors present simultaneously, and the condition appears to become more prevalent with age. However, this does not mean that everyone with one or more of these risk factors will develop NAFLD, and it is not a deterministic checklist. Any concern about personal risk is best discussed with a healthcare professional who can consider the full clinical picture.
What Blood Tests Can Tell You About Liver Health
Blood tests are often among the first investigations considered when assessing liver health. Several markers may be relevant in this context:
- Alanine aminotransferase (ALT): An enzyme found predominantly in liver cells; elevated levels may suggest liver-cell injury, though this is not specific to NAFLD.
- Aspartate aminotransferase (AST): Another enzyme that may be raised in liver disease, though it is also found in muscle and other tissues.
- Alkaline phosphatase (ALP): Elevation may suggest problems affecting the bile ducts or liver, though it may also rise for other reasons.
- Gamma-glutamyl transferase (GGT): Can be raised in fatty liver, alcohol-related liver disease and certain other conditions.
- Bilirubin: A breakdown product of red blood cells processed by the liver; raised levels may indicate impaired liver function.
- Albumin: A protein produced by the liver; low levels may suggest impaired synthetic function in more advanced disease.
When interpreting these results, it is essential to consider the reference range provided alongside a result and the clinical context in which the test was performed. Reference ranges vary between laboratories and may be influenced by factors such as age, sex and medication use.
Important limitations: Abnormal liver blood-test results do not automatically confirm NAFLD, and results within the reference range do not necessarily exclude all liver conditions. NHS Specialist Pharmacy Service guidance notes that liver blood tests can be difficult to interpret in isolation and that results may even fall within the reference range in some forms of advanced liver disease. Blood tests must be interpreted alongside a full clinical assessment.
For readers interested in understanding which biomarkers are typically included in private health assessments, Health Screening Clinic provides information on the range of liver and metabolic markers covered within their private screening assessments, which may be useful context for those considering this type of testing.
Can a Blood Test Diagnose NAFLD?
Direct answer: A blood test can provide useful information about liver health and may identify results outside the expected reference range that warrant further investigation. However, a blood test does not, by itself, establish a diagnosis of NAFLD or MASLD. Diagnosis typically requires a broader assessment that may include medical history, risk-factor review, imaging and, in some cases, specialist evaluation.
NHS guidance confirms that NAFLD is commonly identified after blood tests or scans performed for another reason, and that further testing may be used to assess fat accumulation, exclude other causes of abnormal liver tests and identify any liver damage that may be present.
An assessment for NAFLD or MASLD may involve:
- A detailed medical history, including alcohol intake, medication use and metabolic health background
- Review of relevant risk factors
- Liver function blood tests and metabolic markers
- Liver imaging, such as an ultrasound scan, which can assess for fat accumulation
- Assessment of potential fibrosis using validated scoring tools or, where appropriate, more specialist investigation
- Referral to a hepatologist or gastroenterologist if more complex disease or another liver condition is suspected
This progression — from screening or testing, to abnormal finding, to clinical assessment, to diagnosis — is an important distinction. A private health screening test is a starting point, not a diagnostic endpoint.
What Happens If a Liver Blood Test Is Abnormal?
An abnormal liver blood-test result is not cause for immediate alarm, but it does merit appropriate follow-up. The significance of any result depends on the degree of abnormality, the specific marker involved, the person's wider health context and any other relevant factors.
A healthcare professional may consider:
- Repeating the blood test after a short interval to determine whether the finding is persistent or transient
- Reviewing medications that are known to affect liver enzymes
- Assessing alcohol intake, even at modest levels that could contribute to liver-enzyme elevation
- Evaluating metabolic risk factors, including weight, blood pressure, glucose regulation and cholesterol
- Considering other possible causes of elevated liver markers, such as thyroid conditions, coeliac disease or muscle-related disorders
- Organising further blood tests or arranging liver imaging
- Referring for specialist assessment where clinically appropriate
Management depends entirely on the underlying cause and the individual's circumstances. This article does not provide personalised guidance, and any concern about a specific blood-test result should be discussed with a qualified healthcare professional.
Why Proactive Liver Checks Can Matter
The rationale for proactive liver health assessment rests on a straightforward observation: conditions that develop quietly — without producing clear early symptoms — may be more advanced by the time a person seeks help. Earlier identification of an abnormality can sometimes create an opportunity for appropriate clinical assessment and management at a stage when intervention may be more straightforward.
This does not mean that all liver screening is appropriate for all people, or that testing can guarantee a particular outcome. NHS guidance on health screening acknowledges clearly that screening tests have limitations and can produce both false-positive and false-negative results. Screening is a starting point, not a guarantee.
What proactive liver and metabolic health checks can reasonably offer is a more complete picture of a person's health status at a given point in time, allowing them and their healthcare professional to make more informed decisions about whether further assessment is warranted. For individuals with multiple metabolic risk factors, this can be a meaningful step.
Those considering private health screening as part of a broader approach to preventive health may find it helpful to review information about comprehensive private health assessments from a dedicated screening provider before deciding whether testing is appropriate for their circumstances.
NAFLD, Metabolic Health and Associated Conditions
NAFLD and MASLD do not typically exist in isolation. The condition shares metabolic risk factors with a number of other significant health conditions, and this overlap has important implications for how it is understood and managed.
Associations identified in clinical literature and NHS guidance include:
- Type 2 diabetes — insulin resistance is closely linked to fat accumulation in the liver
- Cardiovascular disease — people with NAFLD may have a higher overall cardiovascular risk profile, though the nature of this relationship is complex
- High blood pressure (hypertension)
- Abnormal cholesterol and lipid levels (dyslipidaemia)
- Chronic kidney disease
- Obesity, particularly abdominal obesity
It is important to be clear that these conditions share metabolic risk pathways rather than being directly caused by one another in a simple linear way. NHS guidance notes that lifestyle changes beneficial for NAFLD management can also positively influence risk factors for cardiovascular disease, chronic kidney disease, hypertension and type 2 diabetes — illustrating why a holistic metabolic approach can be appropriate.
What Lifestyle Factors Support Liver Health?
Although this article cannot provide personalised dietary or exercise guidance, there is broad consensus in clinical literature about the lifestyle factors that support general liver and metabolic health:
- A balanced, varied diet with a focus on whole foods, vegetables, lean protein and reduced refined sugars and processed foods
- Regular physical activity appropriate to the individual's health status and ability
- Achieving and maintaining a healthy weight, where weight loss is clinically appropriate
- Avoiding or significantly limiting alcohol, even when the diagnosis is non-alcoholic fatty liver disease — alcohol places additional burden on the liver
- Not smoking, given the broader cardiovascular and metabolic implications of smoking
- Managing blood glucose, blood pressure and cholesterol through appropriate clinical pathways
- Engaging with regular health reviews to monitor metabolic markers over time
No lifestyle intervention can guarantee the reversal of liver disease in every individual. The response to lifestyle modification depends on the stage of the condition, the person's overall health, the presence of other conditions and other factors best assessed by a healthcare professional.
When Should You Speak to a GP or Healthcare Professional?
It is worth speaking with a GP or appropriate healthcare professional if you:
- Are experiencing persistent or unexplained fatigue without an obvious cause
- Have ongoing discomfort in the upper-right abdomen
- Have received liver blood-test results outside the reference range and have not yet had these reviewed
- Have multiple metabolic risk factors, such as obesity, type 2 diabetes, high blood pressure and elevated cholesterol
- Have known liver abnormalities identified previously and are uncertain whether these have been followed up appropriately
- Are simply concerned about your liver health based on risk factors or family history
Because early NAFLD symptoms are non-specific, a symptom alone does not indicate NAFLD. A healthcare professional is best placed to determine whether further investigation is appropriate.
Red-Flag Liver Symptoms Requiring Prompt Medical Attention
Some symptoms may indicate more significant liver disease and require prompt medical assessment rather than routine follow-up. These include:
- Jaundice — yellowing of the skin or whites of the eyes
- Significant abdominal swelling (ascites), which may feel uncomfortable or tight
- Vomiting blood or material that resembles coffee grounds
- Black or tarry stools, which may indicate bleeding in the upper gastrointestinal tract
- Marked confusion, disorientation or altered behaviour that develops suddenly (hepatic encephalopathy)
- Severe or rapidly worsening symptoms of any kind
These symptoms are not characteristic of early NAFLD; they may indicate a more advanced liver condition or another serious medical problem. If you or someone near you experiences these symptoms, seek urgent medical assistance promptly. For emergencies, call 999 or attend the nearest emergency department.
How Private Health Screening May Fit Into Preventive Care
Private health screening can provide access to blood tests and broader health assessments outside of the NHS, which some people find useful for gaining a clearer picture of their current health status. Depending on the assessment chosen, private screening may include markers relating to:
- Liver health (such as ALT, AST, ALP, GGT, bilirubin and albumin)
- Glucose regulation and diabetes risk (such as fasting glucose and HbA1c)
- Cholesterol and lipid profile
- Kidney function
- Thyroid function
- Markers of inflammation
It is important to approach private screening with realistic expectations. A screening assessment does not diagnose NAFLD, and results — whether reassuring or concerning — should be reviewed in the appropriate clinical context with a qualified professional. The appropriate testing strategy for any individual will depend on their age, symptoms, risk factors, existing conditions and professional advice.
Those who would like to explore what private health screening assessments may include can find further information on the Health Screening Clinic website, a private health-screening provider with information about their available assessment options. Fees, test suitability and appointment availability should be confirmed directly with the provider.
Frequently Asked Questions
What are the first signs of NAFLD?
In many cases, there are no noticeable first signs at all. NAFLD is often identified incidentally when blood tests are carried out for another reason. Where symptoms do occur, they may include fatigue, a general feeling of being unwell or mild discomfort in the upper-right abdomen. These symptoms are non-specific and can occur in many other conditions.
Can you have fatty liver without symptoms?
Yes. Many people with NAFLD experience no symptoms whatsoever, particularly in the earlier stages of the condition. This is one reason why the condition is so frequently identified through blood tests or scans undertaken for an unrelated purpose, rather than through symptom-led investigation.
Can a blood test detect fatty liver?
A blood test cannot definitively detect or diagnose fatty liver disease on its own. Liver blood tests may identify results outside the reference range that could prompt further investigation, but a diagnosis typically requires a broader assessment including medical history, risk-factor review and, commonly, imaging such as an ultrasound. Normal blood-test results do not necessarily exclude liver disease.
Which blood tests are used to assess liver health?
Markers commonly included in liver health assessments include ALT, AST, ALP, GGT, bilirubin and albumin. These provide information about liver-cell integrity, bile-duct function, liver synthetic capacity and other aspects of liver health. Results must be interpreted within their clinical context and alongside the individual's reference range.
Does NAFLD always progress to serious liver disease?
No. Many people with NAFLD remain at the fatty liver (steatosis) stage without developing significant liver inflammation, fibrosis or cirrhosis. The likelihood of progression may be influenced by metabolic factors, lifestyle, the presence of other conditions and individual biological variation. Not everyone with NAFLD will experience serious liver disease.
Should I have a liver health check if I have diabetes or obesity?
If you have type 2 diabetes, obesity or other metabolic risk factors associated with NAFLD, it is reasonable to discuss your liver health with a GP or healthcare professional. They can assess your individual risk profile and recommend appropriate investigations. Private health screening may also offer relevant blood-test assessments, though results should always be interpreted alongside professional clinical advice.
Finding Appropriate Health Screening Information
If you are concerned about liver health or have risk factors associated with fatty liver disease, discussing your concerns with an appropriate healthcare professional can help determine whether further assessment or testing is suitable. Private health-screening services may offer blood tests and broader health assessments, but results should always be interpreted within the appropriate clinical context rather than in isolation.
Health Screening Clinic is a private health-screening provider that offers information about available screening assessments and the biomarkers covered within different health-check options. For those considering private health screening as part of a broader preventive health approach, reviewing what a comprehensive private health screen may include can be a useful first step before deciding whether this type of assessment is suitable. Appointment availability, test suitability and current service details should be confirmed directly with the provider.
Medical and Health-Screening Disclaimer
This article is intended for general informational purposes only and does not constitute medical advice, diagnosis or treatment. Non-alcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), may cause no noticeable symptoms, particularly in its earlier stages. Symptoms and blood-test results alone cannot confirm a diagnosis. If you are concerned about your liver health or have persistent or worsening symptoms, speak with an appropriate healthcare professional. Private health screening does not replace clinical assessment or specialist care where required.
